Implicit|||||||||||Expansion|||||||||||0..312|0|Stage-specific changes in fetal thymocyte proliferation during the CD4-8 - to CD4 +8 + transition in wild type , Rag1 - / - , and Hoxa3 , Pax1 mutant mice Abstract Background : The function of the thymic microenvironment is to promote thymocyte maturation , in part via regulation of thymocyte proliferation and cell death .||||||||314..559|1|Defects in fetal thymic epithelial cell ( TEC ) development and function , and therefore in the formation of a functional microenvironment , can be caused either directly by TEC differentiation defects or indirectly by defective thymocyte maturation .|||||||||||||
Implicit|||||||||||Expansion|||||||||||314..559|1|Defects in fetal thymic epithelial cell ( TEC ) development and function , and therefore in the formation of a functional microenvironment , can be caused either directly by TEC differentiation defects or indirectly by defective thymocyte maturation .||||||||561..722|2|In this paper we studied fetal thymocyte proliferation during the early transition from the CD3-4-8 - ( triple negative , TN ) to CD4 +8 + ( double positive , DP ) stages .|||||||||||||
Implicit|||||||||||Expansion|||||||||||561..722|2|In this paper we studied fetal thymocyte proliferation during the early transition from the CD3-4-8 - ( triple negative , TN ) to CD4 +8 + ( double positive , DP ) stages .||||||||724..878|3|We compared wild type mice with Rag1 - / - mice and with Hoxa3 + / - Pax1 - / - compound mutant mice , which have blocks at different stages of thymocyte development .|||||||||||||
EntRel||||||||||||||||||||||724..878|3|We compared wild type mice with Rag1 - / - mice and with Hoxa3 + / - Pax1 - / - compound mutant mice , which have blocks at different stages of thymocyte development .||||||||880..1078|4|Results : Wild type fetal and adult thymus showed stage-specific differences in the proliferation profiles of developing thymocytes , with fetal stages showing generally higher levels of proliferation .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1080..1338|5|The proliferation profile of fetal thymocytes from Rag1 - / - mutants also had stage-specific increases in proliferation compared to wild type fetal thymocytes , in contrast to the lower proliferation previously reported for thymocytes from adult Rag1 - / - mutants .||||||||1340..1517|6|We have previously shown that Hoxa3 + / - Pax1 - / - mice have abnormal fetal TEC development , resulting in increased apoptosis at the TN to DP transition and decreased DP cell numbers .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1340..1517|6|We have previously shown that Hoxa3 + / - Pax1 - / - mice have abnormal fetal TEC development , resulting in increased apoptosis at the TN to DP transition and decreased DP cell numbers .||||||||1519..1649|7|Fetal thymocytes from Hoxa3 + / - Pax1 - / - compound mutants had increased proliferation , but fewer proliferating cells , at the DP stage .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1880..2045|10|Background Thymocyte development occurs within a complex network of cells , extracellular matrix , and secreted factors referred to as the thymic microenvironment [ 1 ] .||||||||2047..2268|11|Current evidence suggests that this microenvironment is created during fetal thymus organogenesis through stage-dependent interactions between differentiating thymic epithelial cells ( TECs ) and developing thymocytes [ 2-6 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2270..2399|12|Therefore , blocks at different stages of thymocyte development result in differential effects on TEC differentiation and function .||||||||2401..2636|13|Because of the complex interdependence of TEC and thymocyte differentiation , defects in fetal TEC development can be caused either directly by cell-autonomous TEC differentiation defects , or indirectly by defective thymocyte maturation .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2401..2636|13|Because of the complex interdependence of TEC and thymocyte differentiation , defects in fetal TEC development can be caused either directly by cell-autonomous TEC differentiation defects , or indirectly by defective thymocyte maturation .||||||||2638..2779|14|Once a mature thymic environment is formed , many , if not all stages of thymocyte maturation require interactions with thymic epithelial cells .|||||||||||||
EntRel||||||||||||||||||||||2781..2892|15|Therefore , defects in TECs can in turn cause defects in thymocyte differentiation , proliferation , or cell death .||||||||2896..2952|16|Thymocyte differentiation undergoes two main transitions .|||||||||||||
EntRel||||||||||||||||||||||2896..2952|16|Thymocyte differentiation undergoes two main transitions .||||||||2954..3049|17|The first is from the CD3-4-8 - ( triple negative , TN ) to the CD4 +8 + ( double positive , DP ) stages .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2954..3049|17|The first is from the CD3-4-8 - ( triple negative , TN ) to the CD4 +8 + ( double positive , DP ) stages .||||||||3051..3241|18|During this transition , T cell precursors sequentially gain and lose cell surface expression of CD44 and CD25 markers , express the pre-T cell receptor ( pTCR ) , and undergo β-selection [ 2,7-9 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3051..3241|18|During this transition , T cell precursors sequentially gain and lose cell surface expression of CD44 and CD25 markers , express the pre-T cell receptor ( pTCR ) , and undergo β-selection [ 2,7-9 ] .||||||||3243..3507|19|The other transition is from CD4 +8 + DP to CD4 + or CD8 + single positive ( SP ) thymocytes , in which DP cells express CD3 , rearrange their α-TCR , undergo positive and negative selection , and down regulate CD4 or CD8 to become functional CD8 + or CD4 + SP T cells [ 10,11 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3509..3679|20|In addition to functional and cell surface marker changes , each thymocyte differentiation stage is marked by characteristic changes in proliferation and apoptosis [ 12-18 ] .||||||||3683..3842|21|The most well defined role for TECs in directly affecting thymocyte differentiation is to mediate positive selection via expression of MHC molecules [ 11,19-22 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3844..4094|22|However , it is still unclear whether TECs directly promote specific stages of thymocyte differentiation during stages that do not involve MHC-TCR interactions , or whether their role at other stages is primarily to promote cell growth and / or survival .||||||||4096..4329|23|Cytokines produced by TECs have been shown to promote proliferation in early stages of thymocyte development , and have been proposed to regulate apoptosis and differentiation , although their precise roles remain controversial [ 23,24 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4439..4511|25|However , a defined role for TECs at the TN-DP transition remains elusive .||||||||4513..4591|26|Much of the research on this transition has focused on the role of the pre-TCR .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4513..4591|26|Much of the research on this transition has focused on the role of the pre-TCR .||||||||4593..4927|27|Mounting evidence suggests that the pre-TCR does not require interaction with a ligand to perform its function , and the subsequent CD44-25 - ( TN4 or pre-DP ) to DP transition has been termed " programmed differentiation " to indicate that this step can occur in isolated thymocytes , presumably without input from extrinsic signals [ 25-27 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5127..5250|29|The specific nature and purpose of the TEC contribution during this important transition therefore remains to be determined .||||||||5254..5379|30|In order to investigate the regulation of thymocyte development by TECs , we are studying Hoxa3 + / - Pax1 - / - compound mutant mice .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5254..5379|30|In order to investigate the regulation of thymocyte development by TECs , we are studying Hoxa3 + / - Pax1 - / - compound mutant mice .||||||||5381..5532|31|Hoxa3 and Pax1 are transcription factors that act in a common pathway regulating thymus organogenesis and thymic epithelial cell development [ 29,31-34 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5381..5532|31|Hoxa3 and Pax1 are transcription factors that act in a common pathway regulating thymus organogenesis and thymic epithelial cell development [ 29,31-34 ] .||||||||778..948|32|Hoxa3 + / - Pax1 - / - compound mutants have defects in TEC development including reduced numbers of TECs , fewer MHC Class II + TECs , and changes in TEC proliferation and apoptosis .|||||||||||||
Implicit|||||||||||Expansion|||||||||||778..948|32|Hoxa3 + / - Pax1 - / - compound mutants have defects in TEC development including reduced numbers of TECs , fewer MHC Class II + TECs , and changes in TEC proliferation and apoptosis .||||||||5708..5939|33|These TEC defects result in thymocyte maturation defects that include a decrease in total thymocyte number and a 10-fold reduction in the number of DP thymocytes , but an apparently normal transition from the TN3 to the pre-DP stage .|||||||||||||
Implicit|||||||||||Contingency|||||||||||5708..5939|33|These TEC defects result in thymocyte maturation defects that include a decrease in total thymocyte number and a 10-fold reduction in the number of DP thymocytes , but an apparently normal transition from the TN3 to the pre-DP stage .||||||||5941..6037|34|The decrease in DP cells is associated with increased apoptosis in both pre-DP and DP cells [ 29 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6039..6266|35|As the defects at the TN to DP transition in these mutants are caused by defective TEC function rather than thymocyte-intrinsic defects , these mice represent an opportunity to study the role of TECs in promoting this transition .||||||||6270..6505|36|To further investigate the role of TECs in promoting thymocyte death and growth during the TN to DP transition , we assayed the proliferation of specific thymocyte subsets using BrdU incorporation , which detects cycling cells in S-phase .|||||||||||||
Implicit|||||||||||Contingency|||||||||||6270..6505|36|To further investigate the role of TECs in promoting thymocyte death and growth during the TN to DP transition , we assayed the proliferation of specific thymocyte subsets using BrdU incorporation , which detects cycling cells in S-phase .||||||||6507..6590|37|We compared fetal and adult wild type mice with Hoxa3 , Pax1 compound mutants [ 29,34 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6592..6718|38|We also assayed Rag1 - / - mice , which have defects in TEC development due to arrested thymocyte maturation at the TN3 stage [ 35 ] .||||||||6720..6824|39|We found stage-specific differences in proliferation levels between fetal and adult wild type thymocytes .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6826..6922|40|We also found distinct patterns of thymocyte proliferation in the Rag1 - / - and Hoxa3 , Pax1 mutants .||||||||6924..7147|41|The abnormal cell death and proliferation patterns in the Hoxa3 , Pax1 compound mutant fetal thymocytes might be caused in part by observed reductions in the transcription levels of the cytokines IL-7 and SCF produced by TECs .|||||||||||||
Implicit|||||||||||Expansion|||||||||||7367..7523|43|Results As an initial analysis , we compared thymocyte proliferation between thymocytes from late fetal ( E17 .5 ) and adult ( 6 – 8 week ) wild type C57BL6/J mice .||||||||7525..7712|44|Although differences in the proliferation of fetal vs. adult TCR-expressing thymocytes and have been reported [ 36 ] , we were interested in investigating the more immature thymocyte subsets .|||||||||||||
Implicit|||||||||||Expansion|||||||||||7525..7712|44|Although differences in the proliferation of fetal vs. adult TCR-expressing thymocytes and have been reported [ 36 ] , we were interested in investigating the more immature thymocyte subsets .||||||||7714..7884|45|BrdU labeled fetal and adult thymi were analyzed for the percent of proliferating cells in different CD3-4-8 - TN thymocyte subsets defined by CD44 and CD25 expression [ 8 ] .|||||||||||||
EntRel||||||||||||||||||||||7714..7884|45|BrdU labeled fetal and adult thymi were analyzed for the percent of proliferating cells in different CD3-4-8 - TN thymocyte subsets defined by CD44 and CD25 expression [ 8 ] .||||||||7886..7967|46|The CD3 +4 +8 + population was defined by co-staining of all three markers ( Fig. 1A ) .|||||||||||||
EntRel||||||||||||||||||||||7886..7967|46|The CD3 +4 +8 + population was defined by co-staining of all three markers ( Fig. 1A ) .||||||||7969..8104|47|A typical analysis of the BrdU + cells in DP cells and the four CD44 vs. CD25 subsets within the TN cell population is shown in Figure 1 .|||||||||||||
EntRel||||||||||||||||||||||8106..8176|48|Compiled data for each subset from all experiments is shown in Table 1 .||||||||8180..8320|49|The wild type adult ( Fig. 1C , 1F ) and fetal ( Fig. 1D , 1F ) thymocyte proliferation profile patterns differed significantly at specific stages .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8180..8320|49|The wild type adult ( Fig. 1C , 1F ) and fetal ( Fig. 1D , 1F ) thymocyte proliferation profile patterns differed significantly at specific stages .||||||||8322..8417|50|The overall proliferation level in TN cells was increased by 50 % in fetal thymocytes ( p < 0.01 ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8322..8417|50|The overall proliferation level in TN cells was increased by 50 % in fetal thymocytes ( p < 0.01 ) .||||||||8419..8602|51|Most dramatically , the percentages of BrdU + cells in fetal thymocytes were 10-fold higher than in the adult at the earliest , TN1 ( CD44 +25 - ) thymocyte differentiation stage ( P < 0.001 ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8419..8602|51|Most dramatically , the percentages of BrdU + cells in fetal thymocytes were 10-fold higher than in the adult at the earliest , TN1 ( CD44 +25 - ) thymocyte differentiation stage ( P < 0.001 ) .||||||||8604..8701|52|A much lower , but still significant increase was seen in fetal TN2 cells ( 25 % increase , p < 0.01 ) .|||||||||||||
EntRel||||||||||||||||||||||8703..8812|53|Proliferation was also significantly higher at the fetal TN3 stage compared to adult ( 50 % increase , p < 0.01 ) .||||||||8814..8909|54|Proliferation at the TN4/pre-DP ( CD44-25 - ) stage was similar between fetal and adult thymocytes .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9025..9176|56|Therefore , nearly every stage from the earliest TN to the DP stages showed significantly increased proliferation in fetal thymocytes relative to adults .||||||||9180..9416|57|It was possible that the lower percentage of proliferating cells seen in the TN1 population in adults was due to an increased number of B cells and NK cells in the adult thymus , which would not have been excluded in our initial analysis .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9180..9416|57|It was possible that the lower percentage of proliferating cells seen in the TN1 population in adults was due to an increased number of B cells and NK cells in the adult thymus , which would not have been excluded in our initial analysis .||||||||9418..9621|58|As this was one of the most striking differences seen between fetal and adult stages , we repeated this analysis adding antibodies against B220 and NK1 .1 to CD3 , 4 and 8 in the excluded gate ( Fig. 1G , 1H ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9418..9621|58|As this was one of the most striking differences seen between fetal and adult stages , we repeated this analysis adding antibodies against B220 and NK1 .1 to CD3 , 4 and 8 in the excluded gate ( Fig. 1G , 1H ) .||||||||9623..9809|59|Even excluding these cell populations , there is still a significantly lower percentage of proliferating cells in the TN1 population in the adult thymus than in the fetal thymus ( Fig. 1I ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9921..10033|61|We also compared proliferation of fetal thymocytes from Rag1 - / - mice to the results obtained from wild type mice .||||||||10035..10225|62|Thymocytes in the adult Rag1 - / - thymus have been previously shown to have overall lower levels of proliferation than adult wild type TN thymocytes [ 13 ] , particularly at the TN3 stage [ 37-40 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10227..10396|63|At fetal stages , our results showed that proliferation also varied between thymocytes in the wild type and Rag1 - / - thymus at discrete stages of thymocyte differentiation .||||||||10398..10533|64|At the earliest TN1 stage , thymocyte proliferation levels in Rag1 - / - thymi were similar to fetal wild type cells ( Fig. 1E , 1F ; Table 1 ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10398..10533|64|At the earliest TN1 stage , thymocyte proliferation levels in Rag1 - / - thymi were similar to fetal wild type cells ( Fig. 1E , 1F ; Table 1 ) .||||||||10535..10673|65|At the TN2 stage , fetal thymocytes from Rag1 - / - mice had a proliferation level nearly twice that of wild type fetal thymocytes ( p < 0.001 ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10535..10673|65|At the TN2 stage , fetal thymocytes from Rag1 - / - mice had a proliferation level nearly twice that of wild type fetal thymocytes ( p < 0.001 ) .||||||||10675..10882|66|By the TN3 stage , the percentage of proliferating Rag1 - / - thymocytes had dropped slightly below that of wild type fetal thymocytes ( ~ 30 % decrease , p < 0.01 ) , equal to wild type adult TN3 proliferation levels .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11053..11258|68|These results with Rag1 - / - fetal thymocytes contrast with thymocytes in the Rag - / - adult , which have much lower proliferation than wild type adult thymocytes at all stages of thymocyte differentiation [ 13 ] .||||||||11262..11524|69|Our previous analysis of the Hoxa3 + / - Pax1 - / - compound mutant thymocyte phenotype showed a specific partial block at the TN to DP transition , associated with increased apoptosis at both the TN4/pre-DP and DP subsets , and a 10-fold decrease in DP cell numbers [ 29 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11262..11524|69|Our previous analysis of the Hoxa3 + / - Pax1 - / - compound mutant thymocyte phenotype showed a specific partial block at the TN to DP transition , associated with increased apoptosis at both the TN4/pre-DP and DP subsets , and a 10-fold decrease in DP cell numbers [ 29 ] .||||||||11526..11675|70|Using BrdU analysis , we compared the proliferation of Hoxa3 + / - Pax1 - / - fetal thymocytes during the TN to DP transition compared to littermate controls .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11526..11675|70|Using BrdU analysis , we compared the proliferation of Hoxa3 + / - Pax1 - / - fetal thymocytes during the TN to DP transition compared to littermate controls .||||||||11677..11971|71|Thymocyte proliferation levels for all genotypes ( Hoxa3 + / - , Pax1 + / - , Pax1 - / - , and Hoxa3 + / - Pax1 - / - ) were similar to wild type in all of the canonical TN1-TN4 stages ( Fig. 2A ,2 B ,2 C ; Table 1 ) , consistent with the normal percentages and cell numbers for these subpopulations previously reported [ 29 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11677..11971|71|Thymocyte proliferation levels for all genotypes ( Hoxa3 + / - , Pax1 + / - , Pax1 - / - , and Hoxa3 + / - Pax1 - / - ) were similar to wild type in all of the canonical TN1-TN4 stages ( Fig. 2A ,2 B ,2 C ; Table 1 ) , consistent with the normal percentages and cell numbers for these subpopulations previously reported [ 29 ] .||||||||11973..12265|72|Recent papers by Penit , et al. have provided data from cell cycle analysis suggesting that a discrete CD44-25lo population with a specific proliferation profile can be identified , such that the transition from TN3 to DP can be further subdivided into CD25hi , CD25lo , and CD25 - subsets [ 12,13 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11973..12265|72|Recent papers by Penit , et al. have provided data from cell cycle analysis suggesting that a discrete CD44-25lo population with a specific proliferation profile can be identified , such that the transition from TN3 to DP can be further subdivided into CD25hi , CD25lo , and CD25 - subsets [ 12,13 ] .||||||||12267..12424|73|Analysis of proliferation using these more narrowly defined subsets still showed values similar to wild type in the CD44-25lo subset ( Fig. 2D ,2 E ,2 F ; Table 2 ) .|||||||||||||
EntRel||||||||||||||||||||||12426..12563|74|In contrast , the proliferation level of DP cells increased nearly 2-fold in compound mutants compared to wild type ( Fig. 2C , 2F ; Table 1 ) .||||||||12565..12801|75|In spite of this increase in the percentage of proliferating cells , the actual number of BrdU + DP cells was reduced 4-fold compared to wild type in the compound mutants ( 15.03 ± 8.73 × 104 vs. 61.94 ± 32.12 × 104 in wild type ; p < 0.01 ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12565..12801|75|In spite of this increase in the percentage of proliferating cells , the actual number of BrdU + DP cells was reduced 4-fold compared to wild type in the compound mutants ( 15.03 ± 8.73 × 104 vs. 61.94 ± 32.12 × 104 in wild type ; p < 0.01 ) .||||||||12803..12884|76|The numbers of proliferating cells at the pre-DP stage were unchanged ( not shown ) .|||||||||||||
Implicit|||||||||||Contingency|||||||||||12803..12884|76|The numbers of proliferating cells at the pre-DP stage were unchanged ( not shown ) .||||||||12886..13069|77|Combined with our previous results , this result shows that both increased apoptosis and reduced proliferation contribute to the decrease in DP cells in the Hoxa3 , Pax1 compound mutants .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13071..13193|78|Unfortunately , Hoxa3 + / - Pax1 - / - mice die at birth , preventing analysis of thymocyte proliferation in adult compound mutants .||||||||4096..4263|79|Cytokines produced by TECs are good candidates for mediating at least some of these changes in thymocyte proliferation and apoptosis in the Hoxa3 , Pax1 compound mutants .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4096..4263|79|Cytokines produced by TECs are good candidates for mediating at least some of these changes in thymocyte proliferation and apoptosis in the Hoxa3 , Pax1 compound mutants .||||||||13366..13531|80|Using semi-quantitative RT-PCR , we analyzed the expression of two cytokines that are produced by TECs , IL-7 and SCF , in pooled , genotype-matched E14 .5 thymi ( Fig. 3 ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13366..13531|80|Using semi-quantitative RT-PCR , we analyzed the expression of two cytokines that are produced by TECs , IL-7 and SCF , in pooled , genotype-matched E14 .5 thymi ( Fig. 3 ) .||||||||778..925|81|Hoxa3 + / - Pax1 - / - compound mutants had decreased transcription of both cytokines relative to all other genotypes , including Pax1 - / - single mutants .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13679..13835|82|However , Hoxa3 + / - Pax1 - / - compound mutants were not completely missing either cytokine analyzed , and the magnitude of the decrease was variable between pools .||||||||13839..14049|83|To test whether the changes in cytokine levels were responsible for the observed thymocyte development phenotypes , we attempted to rescue these phenotypes by supplementation in fetal thymic organ culture ( FTOC ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13839..14049|83|To test whether the changes in cytokine levels were responsible for the observed thymocyte development phenotypes , we attempted to rescue these phenotypes by supplementation in fetal thymic organ culture ( FTOC ) .||||||||14051..14171|84|E15 .5 embryonic thymic lobes from individual embryos were cultured separately in FTOC , with or without added IL-7 or SCF .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14051..14171|84|E15 .5 embryonic thymic lobes from individual embryos were cultured separately in FTOC , with or without added IL-7 or SCF .||||||||14173..14472|85|Cultures from control genotypes ( wild type , Pax1 + / - , Hoxa3 + / - , Pax1 - / - ) behaved as expected [ 41-46 ] , with addition of IL-7 causing an increase in the percentage of DN cells and a corresponding decrease in DP cells , while adding SCF had no significant effect on thymocyte development ( data not shown ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14605..14732|87|In fact , separated lobes cultured under identical conditions in the absence of any added cytokines had widely differing results .||||||||14734..14967|88|Changes in thymocyte cell number and differentiation after culture were highly variable ; for example , cell numbers could differ stochastically after culture by as much as 10-fold between two lobes from the same compound mutant embryo .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14734..14967|88|Changes in thymocyte cell number and differentiation after culture were highly variable ; for example , cell numbers could differ stochastically after culture by as much as 10-fold between two lobes from the same compound mutant embryo .||||||||14969..15129|89|This result was never obtained with separately cultured thymic lobes from any other genotype , which always developed identically when cultured without cytokines .|||||||||||||
Implicit|||||||||||Expansion|||||||||||15319..15426|91|Discussion In this study , we have examined thymocyte proliferation in the fetal and adult wild type thymus .||||||||15428..15598|92|Our results showed clear stage-specific differences in wild type thymocyte proliferation depending on the developmental age of the microenvironment ( i.e. fetal vs. adult ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||15795..16018|94|Abnormal TEC development in both of these mutant strains resulted in both increases and decreases in thymocyte proliferation in a stage-specific manner , rather than simply an overall reduced ability to promote proliferation .||||||||16022..16206|95|There is considerable evidence that thymopoiesis differs in the fetal thymus during the initial creation of the microenvironment , as opposed to adult thymus function ( reviewed in [ 47 ] ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16022..16206|95|There is considerable evidence that thymopoiesis differs in the fetal thymus during the initial creation of the microenvironment , as opposed to adult thymus function ( reviewed in [ 47 ] ) .||||||||16208..16396|96|Differences have been reported in responses to some cytokines , in signaling at the TN-DP transition in fetal compared to adult thymus , and in proliferation of CD4 + SP thymocytes [ 36,48-50 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16208..16396|96|Differences have been reported in responses to some cytokines , in signaling at the TN-DP transition in fetal compared to adult thymus , and in proliferation of CD4 + SP thymocytes [ 36,48-50 ] .||||||||1080..1281|97|The proliferation profiles of both wild type and Rag - / - fetal thymocytes support the hypothesis that fetal thymocyte maturation is fundamentally different from thymocyte development in the adult thymus .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1080..1281|97|The proliferation profiles of both wild type and Rag - / - fetal thymocytes support the hypothesis that fetal thymocyte maturation is fundamentally different from thymocyte development in the adult thymus .||||||||16601..16705|98|The TN1 and DP stages both show increased proliferation in wild-type fetal thymocytes compared to adults .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16601..16705|98|The TN1 and DP stages both show increased proliferation in wild-type fetal thymocytes compared to adults .||||||||16707..16808|99|This difference at the TN1 stage is not due to the presence of more B or NK cells in the adult thymus .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16810..17024|100|Although it is formally possible that some other cell type may still be included in our TN1 population , this analysis strongly suggests that TN1 cells have different proliferation profiles in fetal and adult thymus .||||||||17028..17312|101|It has been well documented that thymocytes in adult Rag1 or Rag2 mutants have dramatically reduced proliferation compared to wild type , particularly at the TN3 stage [ 37-40 ] , and Penit et al. reported 2 – 10 fold reductions at every stage of thymocyte development in Rag - / - adults [ 13 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17028..17312|101|It has been well documented that thymocytes in adult Rag1 or Rag2 mutants have dramatically reduced proliferation compared to wild type , particularly at the TN3 stage [ 37-40 ] , and Penit et al. reported 2 – 10 fold reductions at every stage of thymocyte development in Rag - / - adults [ 13 ] .||||||||17314..17507|102|Recent work by Petrie , et al. has shown that this reduced proliferation is not intrinsic to Rag mutant thymocytes , but rather is secondary to thymic microenvironment defects in Rag mutants [ 37 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17314..17507|102|Recent work by Petrie , et al. has shown that this reduced proliferation is not intrinsic to Rag mutant thymocytes , but rather is secondary to thymic microenvironment defects in Rag mutants [ 37 ] .||||||||17509..17756|103|Our results show that at fetal stages , Rag mutant thymocytes have a proliferation profile that is much more similar to wild type thymocytes at the same stage , with less than a 2-fold difference in the percentage of proliferating cells at any stage .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17758..17979|104|For example , TN3 stage thymocytes in the Rag - / - adult thymus have proliferation levels 3-fold below wild type thymus [ 13,37 ] , while in the Rag - / - fetal thymus TN3 cells are only 25 – 30 % lower than in wild type fetal thymus .||||||||17981..18089|105|Proliferation is not changed at all stages , and is actually increased relative to wild type at the TN2 stage .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17981..18089|105|Proliferation is not changed at all stages , and is actually increased relative to wild type at the TN2 stage .||||||||18091..18368|106|This increase at the TN2 stage may be due to the failure of TN2 cells to initiate TCRβ gene rearrangement at this stage , which is normally associated with decreased proliferation.Rag - / - mutants have a profound thymocyte development block at the TN3 to TN4/preDP transition [ 51 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||18091..18368|106|This increase at the TN2 stage may be due to the failure of TN2 cells to initiate TCRβ gene rearrangement at this stage , which is normally associated with decreased proliferation.Rag - / - mutants have a profound thymocyte development block at the TN3 to TN4/preDP transition [ 51 ] .||||||||18370..18506|107|During normal wild type fetal thymus development , significant DP cell development does not occur until E16 .5 in most genetic backgrounds .|||||||||||||
Implicit|||||||||||Expansion|||||||||||18508..18741|108|As a result , at E17 .5 the thymic microenvironment in Rag mutants has not been exposed to abnormal thymocyte development for very long , and has not yet developed the full phenotype seen in the steady state adult Rag mutant thymus [ 35 ] .||||||||18745..18937|109|In the Hoxa3 , Pax1 compound mutants , cell-autonomous TEC defects cause a partial block at the DN-DP transition , so thymocytes do progress to DP and SP stages , albeit at reduced frequencies [ 29 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||18745..18937|109|In the Hoxa3 , Pax1 compound mutants , cell-autonomous TEC defects cause a partial block at the DN-DP transition , so thymocytes do progress to DP and SP stages , albeit at reduced frequencies [ 29 ] .||||||||18939..19042|110|TEC defects are seen as early as E12 .5 in these mutants , from the earliest stages of organogenesis [ 34 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||19044..19175|111|Therefore , the TEC defects in these mice would be expected to have different effects on thymocyte proliferation than in Rag mutants .||||||||19177..19266|112|In this study , we found stage-specific changes in thymocyte proliferation at the DP stage .|||||||||||||
Implicit|||||||||||Expansion|||||||||||19177..19266|112|In this study , we found stage-specific changes in thymocyte proliferation at the DP stage .||||||||11262..11395|113|Our previous analysis reported decreased DP cell number and increased apoptosis in both the pre-DP and DP stages in these mutants [ 29 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11262..11395|113|Our previous analysis reported decreased DP cell number and increased apoptosis in both the pre-DP and DP stages in these mutants [ 29 ] .||||||||19404..19518|114|DP cell numbers in both this and our previous study were decreased 10-fold in the Hoxa3 + / - Pax1 - / - compound mutants .|||||||||||||
Implicit|||||||||||Expansion|||||||||||19404..19518|114|DP cell numbers in both this and our previous study were decreased 10-fold in the Hoxa3 + / - Pax1 - / - compound mutants .||||||||19520..19646|115|At first glance , the increase in the percentage of proliferating cells at the DP stage appears contradictory to this phenotype .|||||||||||||
Implicit|||||||||||Expansion|||||||||||19762..20023|117|In contrast , pre-DP cells did not have a change in the number or percentage of proliferating cells , suggesting that the signals promoting proliferation of these cells is still present , and that proliferation of DP and pre-DP cells may be regulated independently .||||||||20025..20170|118|Pre-DP cells do have a three-fold increase in apoptosis [ 29 ] , suggesting that separate signals regulate proliferation and survival of these cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12886..13146|119|Combined with our previous data , this result suggests that the decrease in DP cell numbers seen in the Hoxa3-Pax1 compound mutants is both due to an increase in the number of pre-DP and DP cells undergoing apoptosis as well as a decrease in the number of proliferating DP .||||||||20447..20610|120|Insufficiencies of multiple cytokines might be involved in the changes in proliferation and cell death at the CD44-25 - and DP stages in Hoxa3-Pax1 compound mutants .|||||||||||||
Implicit|||||||||||Expansion|||||||||||20447..20610|120|Insufficiencies of multiple cytokines might be involved in the changes in proliferation and cell death at the CD44-25 - and DP stages in Hoxa3-Pax1 compound mutants .||||||||20612..20753|121|SCF and IL-7 are first expressed as early as E12 .5 in the developing thymus , well before significant thymocyte maturation takes place [ 52,53 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||20612..20753|121|SCF and IL-7 are first expressed as early as E12 .5 in the developing thymus , well before significant thymocyte maturation takes place [ 52,53 ] .||||||||20755..20931|122|Although the number of TECs is reduced by about 2-fold in Hoxa3 + / - Pax1 - / - compound mutants , the number of thymocytes is reduced by a slightly greater amount , around 3-fold [ 29 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||21074..21240|124|In fact , these mutants should have a relative increase in the proportion of TECs , making the reductions seen in cytokine levels in the mutant thymi even more striking .||||||||21242..21483|125|The reduced expression of these cytokines in Hoxa3 + / - Pax1 - / - compound mutants could be an indirect effect of defective TEC differentiation , or could be direct downstream targets since both Hoxa3 and Pax1 are expressed in fetal thymus [ 54,55 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||21242..21483|125|The reduced expression of these cytokines in Hoxa3 + / - Pax1 - / - compound mutants could be an indirect effect of defective TEC differentiation , or could be direct downstream targets since both Hoxa3 and Pax1 are expressed in fetal thymus [ 54,55 ] .||||||||21485..21707|126|Comparison of the Hoxa3 + / - Pax1 - / - phenotype with those of cytokine mutants do not reveal many similarities [ 30,46,56-61 ] , probably because of the simultaneous reductions in multiple cytokines in the Hoxa3 + / - Pax1 - / - mutants .|||||||||||||
Implicit|||||||||||Expansion|||||||||||21790..21959|128|Therefore , changes in multiple cytokines in Hoxa3 + / - Pax1 - / - mutants would be expected to have complex effects on thymocyte development that could be difficult to predict .||||||||21963..22094|129|Interpretation of the observed phenotype is further complicated by the fact that none of the cytokines tested are completely absent .|||||||||||||
Implicit|||||||||||Expansion|||||||||||21963..22094|129|Interpretation of the observed phenotype is further complicated by the fact that none of the cytokines tested are completely absent .||||||||22096..22310|130|A striking example is the complete absence of γδTCR + thymocyte development in IL-7 mutants , in contrast to normal γδTCR + cell development in Hoxa3 + / - Pax1 - / - mutants [ 29 ] , which have dramatically reduced IL-7 levels .|||||||||||||
Implicit|||||||||||Contingency|||||||||||22096..22310|130|A striking example is the complete absence of γδTCR + thymocyte development in IL-7 mutants , in contrast to normal γδTCR + cell development in Hoxa3 + / - Pax1 - / - mutants [ 29 ] , which have dramatically reduced IL-7 levels .||||||||22312..22429|131|This result suggests that although γδTCR + cell development requires IL-7 , low levels are sufficient for this function .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22636..22809|133|It is also possible that some of the differences seen between Hoxa3 + / - Pax1 - / - and cytokine mutant phenotypes reflect different effects of cytokines at fetal and adult stages .||||||||22811..23017|134|Studies of IL-7R mutants showed relatively normal thymocyte maturation at fetal stages , albeit with reduced thymocyte numbers , in contrast to a severe block in thymocyte differentiation in adult thymus [ 49 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23181..23387|136|Conclusions Our results show that fetal and adult wild type thymocytes have stage-specific differences in proliferation , with both TN1 and DP cells exhibiting higher levels of proliferation in fetal thymus .||||||||23389..23515|137|This fetal wild-type profile was very similar to that seen for fetal Rag mutant thymocytes , in contrast to adult Rag - / - thymus .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23517..23725|138|Therefore , the changes in proliferation seen in the fetal Rag mutant thymocytes reflect the earliest microenvironment changes occurring as a result of defective TEC-thymocyte interactions in the Rag - / - thymus .||||||||23729..23958|139|The current study further supports a role for TECs in regulating both thymocyte proliferation and survival during the DN-DP transition , and suggests that proliferation and apoptosis of TN4 and DP cells are regulated independently .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23729..23958|139|The current study further supports a role for TECs in regulating both thymocyte proliferation and survival during the DN-DP transition , and suggests that proliferation and apoptosis of TN4 and DP cells are regulated independently .||||||||23960..24165|140|Our results provide direct genetic evidence for these functions of TECs , by showing that these processes are defective in mutants with a primary TEC differentiation defect ( the Hoxa3 , Pax1 compound mutants ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24279..24420|142|Methods Hoxa3 + / - Pax1 + / - mice were mated to Pax1 + / - or Pax1 - / - mice and genotyped for both Hoxa3 and Pax1 by PCR as described previously [ 29 ] .||||||||24422..24484|143|Comparisons were made between littermates from the same colony .|||||||||||||
EntRel||||||||||||||||||||||24422..24484|143|Comparisons were made between littermates from the same colony .||||||||24486..24559|144|Rag1 - / - mice ( Jackson Labs ) were maintained as a homozygous mutant colony .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24486..24559|144|Rag1 - / - mice ( Jackson Labs ) were maintained as a homozygous mutant colony .||||||||24561..24629|145|All mice were maintained as congenic on a C57BL/6 genetic background .|||||||||||||
EntRel||||||||||||||||||||||24561..24629|145|All mice were maintained as congenic on a C57BL/6 genetic background .||||||||24631..24682|146|Noon of the day of vaginal plug was considered E0 .5 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24684..24816|147|All animal use procedures were approved by the Medical College of Georgia Committee on Animal Use for Research and Education ( CAURE ) .||||||||24820..25056|148|Fetal thymocyte in vivo BrdU incorporation was done by intraperitoneal injection of BrdU ( 5-Bromo-2 ' - Deoxyuridine ; Sigma ) on the morning of E17 .5 , two doses per mouse and 1 mg per dose with a 0.5 hour pause , as previously described [ 13 ] .|||||||||||||
Implicit|||||||||||Temporal|||||||||||24820..25056|148|Fetal thymocyte in vivo BrdU incorporation was done by intraperitoneal injection of BrdU ( 5-Bromo-2 ' - Deoxyuridine ; Sigma ) on the morning of E17 .5 , two doses per mouse and 1 mg per dose with a 0.5 hour pause , as previously described [ 13 ] .||||||||25058..25220|149|Two hours after the first injection , fetal thymi were isolated by dissection and single-cell suspensions prepared by passing the thymocytes through cell strainers .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25222..25342|150|Adult thymocyte in vivo BrdU incorporation was done by the same injection protocol using 6 – 8 week old C57BL/6 adult mice .||||||||25346..25713|151|Four-color flow cytometry was performed using the following monoclonal antibodies ( Pharmingen ) : biotin anti-mouse CD25 ( clone : 7D4 ) visualized with Per-CP conjugated streptavidin ; APC anti-mouse CD44 ( clone : IM7 ) ; and three phycoerythrin ( PE ) conjugated antibodies : anti-mouse CD4 ( clone : RM4-5 ) , anti-mouse CD8a ( clone : 53 – 6.7 ) , and anti-mouse CD3ε ( clone : 145-2C11 ) .|||||||||||||
Implicit|||||||||||Temporal|||||||||||25715..25834|152|In some experiments , PE conjugated antibodies against B220 ( clone : RA3-6B2 ) and NK1 .1 ( clone : PK136 ) were also included .||||||||25836..25937|153|After cell surface staining , the cells were fixed with 2 % paraformaldehyde ( PFA ) / PBS at 4 ° C overnight .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26108..26173|155|Cells were then stained with FITC anti-BrdU antibody ( Pharmingen ) .||||||||26175..26351|156|Data were collected by selectively gating either CD3-4-8 - or CD3 +4 +8 + populations ( Becton Dickinson dual laser FACSCalibur ) , and analyses were performed with Cellquest software .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26353..26443|157|Significant differences were determined by the unpaired Student 's t-test or ANOVA analysis .||||||||26447..26552|158|E14 .5 fetal thymic lobes were collected and stored in the TRIzol ( GIBCO BRL ) at -70 ° C until RNA isolation .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26447..26552|158|E14 .5 fetal thymic lobes were collected and stored in the TRIzol ( GIBCO BRL ) at -70 ° C until RNA isolation .||||||||26554..26706|159|Pools of 5-to10 thymi from embryos of the same genotype were homogenized using Micro Pellet Pestles ( Nalge Nunc International ) in 1.5 ml-eppendorf tubes .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26554..26706|159|Pools of 5-to10 thymi from embryos of the same genotype were homogenized using Micro Pellet Pestles ( Nalge Nunc International ) in 1.5 ml-eppendorf tubes .||||||||26708..26845|160|RNA was isolated and the genomic DNA was depleted by using DNaseI ( Amplification Grade , GIBCO BRL ) following the manufacturer 's protocols .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26708..26845|160|RNA was isolated and the genomic DNA was depleted by using DNaseI ( Amplification Grade , GIBCO BRL ) following the manufacturer 's protocols .||||||||26847..26977|161|Reverse transcription of 1 μg of total RNA to cDNA was done using SuperScript II following the manufacturer 's protocol ( GIBCO BRL ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26847..26977|161|Reverse transcription of 1 μg of total RNA to cDNA was done using SuperScript II following the manufacturer 's protocol ( GIBCO BRL ) .||||||||26979..27104|162|Equal amounts of cDNA from different genotypes were added to a final 20 μl PCR reaction mixture using the QIAGEN Taq PCR kits .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26979..27104|162|Equal amounts of cDNA from different genotypes were added to a final 20 μl PCR reaction mixture using the QIAGEN Taq PCR kits .||||||||27106..27294|163|PCR conditions were : 94 ° C 30 sec , 50 ° C 1 min , 72 ° C 1 min for IL-7 , SCF and their internal control β-actin ; or 94 ° C 30 sec , 60 ° C 1 min , 72 ° C 1 min for TGFβ1 and its internal control β-actin .|||||||||||||
EntRel||||||||||||||||||||||27106..27294|163|PCR conditions were : 94 ° C 30 sec , 50 ° C 1 min , 72 ° C 1 min for IL-7 , SCF and their internal control β-actin ; or 94 ° C 30 sec , 60 ° C 1 min , 72 ° C 1 min for TGFβ1 and its internal control β-actin .||||||||27296..27391|164|PCR products were visualized by 5 % acrylamide gel electrophoresis and ethidium bromide staining .|||||||||||||
EntRel||||||||||||||||||||||27296..27391|164|PCR products were visualized by 5 % acrylamide gel electrophoresis and ethidium bromide staining .||||||||27393..27517|165|Band densities were measured and analyzed using the Molecular Analyst software package ( Bio-Rad Laboratories , Version 1.4.1 ) .|||||||||||||
EntRel||||||||||||||||||||||27519..27929|166|Primer sequences were : IL-7 [ 65 ] : IL-7 ( 5 ' ) 5 ' ACT ACA CCC ACC TCC CGC A3 ' ; IL-7 ( 3 ' ) 5 ' TCT CAG TAG TCT CTT TAG G3 ' ; SCF [ 65 ] : SCF ( 5 ' ) 5 ' TCT TCA ACT GCT CCT ATT T3 ' ; SCF ( 3 ' ) 5 ' ACT GCT ACT GCT GTC ATT C3 ' ; TGFβ1 [ 66 ] : TGFβ1 ( 5 ' ) 5 ' GCG GAC TAC TAT GCT AAA GAG G3 ' ; TGFβ1 ( 3 ' ) 5 ' GTT GTG TTG GTT GTA GAG GGC A3 ' ; β-actin [ 67 ] : β-actin ( 5 ' ) 5 ' GGG TCA GAA GGA CTC CTA TG3 ' ; β-actin ( 3 ' ) 5 ' GTA ACA ATG CCA TGT TCA AT3 ' .||||||||27933..27979|167|Thymic lobes were dissected from E15 .5 embryos .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27933..27979|167|Thymic lobes were dissected from E15 .5 embryos .||||||||27981..28094|168|The two lobes from each embryo cultured separately in high oxygen submersion culture as previously described [ 41 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27981..28094|168|The two lobes from each embryo cultured separately in high oxygen submersion culture as previously described [ 41 ] .||||||||28096..28229|169|Fetal thymic organ cultures were supplemented with 100 u/ml of IL-7 or 20 ng/ml of SCF ( Pepro Tech Inc. ) as previously described [ 41 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||28096..28229|169|Fetal thymic organ cultures were supplemented with 100 u/ml of IL-7 or 20 ng/ml of SCF ( Pepro Tech Inc. ) as previously described [ 41 ] .||||||||28231..28362|170|For each embryo , one lobe was treated while the other was cultured in parallel without supplemental cytokine as an internal control .|||||||||||||
Implicit|||||||||||Temporal|||||||||||28231..28362|170|For each embryo , one lobe was treated while the other was cultured in parallel without supplemental cytokine as an internal control .||||||||28364..28462|171|In control experiments , lobes were cultured separately under identical conditions without cytokine .|||||||||||||
Implicit|||||||||||Expansion|||||||||||28848..29188|176|Figure and Table captions Figure 1 : DNA synthesis patterns of fetal vs. adult thymocyte subsets as measured by incorporation of BrdU A. Thymocytes were gated as either CD3-4-8 - TN or CD3 +4 +8 + DP by cell surface marker expression and forward scatter ( SP cells should be located between these two gates , and therefore excluded from analysis ) .||||||||29190..29261|177|B. Gate used for analysis of BrdU incorporation on gated subpopulations .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29190..29261|177|B. Gate used for analysis of BrdU incorporation on gated subpopulations .||||||||29263..29424|178|Panels C-E show CD44 vs. CD25 dot plots of the gated CD3-4-8 - population from 5 – 6 week old adult C57BL/6 ( C ) , E17 .5 fetal C57BL/6 ( D ) , and E17 .5 fetal RAG - / - ( E ) .|||||||||||||
EntRel||||||||||||||||||||||29263..29424|178|Panels C-E show CD44 vs. CD25 dot plots of the gated CD3-4-8 - population from 5 – 6 week old adult C57BL/6 ( C ) , E17 .5 fetal C57BL/6 ( D ) , and E17 .5 fetal RAG - / - ( E ) .||||||||29426..29464|179|Percentages are shown in each quadrant .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29426..29464|179|Percentages are shown in each quadrant .||||||||29466..29577|180|F. Percentages of BrdU + cells ( Mean ± SEM ) in each subset of TN cells defined by CD44 and CD25 , and in DP cells .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29466..29577|180|F. Percentages of BrdU + cells ( Mean ± SEM ) in each subset of TN cells defined by CD44 and CD25 , and in DP cells .||||||||29579..29642|181|G. Adult wild-type thymocytes were gated as CD3-4-8-B220-NK1 .1 - .|||||||||||||
EntRel||||||||||||||||||||||29579..29642|181|G. Adult wild-type thymocytes were gated as CD3-4-8-B220-NK1 .1 - .||||||||29644..29703|182|H. CD44 vs. CD25 dot plots of the gated population from ( G ) .|||||||||||||
EntRel||||||||||||||||||||||29705..29812|183|I. Percentage of BrdU + cells ( mean ± SEM ) in adult and fetal TN1 thymocytes excluding B and NK cells ( H , G ) .||||||||29815..29907|184|Figure 2 : Proliferation of E17 .5 Hoxa3-Pax1 compound mutant thymocytes compared to wild type .|||||||||||||
EntRel||||||||||||||||||||||29815..29907|184|Figure 2 : Proliferation of E17 .5 Hoxa3-Pax1 compound mutant thymocytes compared to wild type .||||||||29909..30037|185|Panels A-B show CD44 vs. CD25 dot plots of the gated CD3-4-8 - population from E17 .5 wild type ( A ) and Hoxa3 + / - Pax1 - / - ( B ) thymus .|||||||||||||
EntRel||||||||||||||||||||||29909..30037|185|Panels A-B show CD44 vs. CD25 dot plots of the gated CD3-4-8 - population from E17 .5 wild type ( A ) and Hoxa3 + / - Pax1 - / - ( B ) thymus .||||||||29426..29464|186|Percentages are shown in each quadrant .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29426..29464|186|Percentages are shown in each quadrant .||||||||30079..30196|187|C. Percentages of BrdU + cells ( Mean ± SEM ) in each of 4 subsets of TN cells defined by CD44 and CD25 , and in DP cells .|||||||||||||
EntRel||||||||||||||||||||||30079..30196|187|C. Percentages of BrdU + cells ( Mean ± SEM ) in each of 4 subsets of TN cells defined by CD44 and CD25 , and in DP cells .||||||||30198..30305|188|D , E. CD44 vs. CD25 dot plots of the gated CD3-4-8 - population divided into five subsets as defined by [ 12 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29466..29830|189|F. Percentages of BrdU + cells ( Mean ± SEM ) in each of 3 CD44 - TN subsets defined in panels D and E. DP values shown for comparison are the same as in C. Figure 3 : Expression of cytokines in fetal thymi of Hoxa3 + / - Pax1 - / - mice and controls measured by semi-quantitative RT-PCR Each lane contains pooled cDNA from 5 – 10 E14 .5 embryonic thymi of the same genotype .||||||||30669..30749|190|Representative results from one of three experiments for each cytokine are shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||30669..30749|190|Representative results from one of three experiments for each cytokine are shown .||||||||30751..30780|191|β-actin was used as a control .|||||||||||||
